Ana Rita Pires

Ana Rita Pires

Auto-generated profile, based on publicly available information

Ana Rita Pires

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
Valter R FonsecaValter R Fonseca
Valter R Fonseca
AAAna Agua-Doce
Ana Agua-Doce
AMAna Raquel Maceiras
Ana Raquel Maceiras
WPWim Pierson
Wim Pierson
FRFilipa Ribeiro
Filipa Ribeiro
LGLuis Graca
Luis Graca
Circulating human T follicular regulatory (T fr ) cells are distinct from tissue T fr cells.

1 January 2015 in Journal of Autoimmunity
Verified
Journal Article
Closed access
ICIris Caramalho
Iris Caramalho
VNVânia Nunes-Silva
Vânia Nunes-Silva
APAna R. Pires
Ana R. Pires
CMCatarina Mota
Catarina Mota
APAna Isabel Pinto
Ana Isabel Pinto
ASAna E Sousa
Ana E Sousa

19 February 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
SSSusana L. Silva
Susana L. Silva
AAAdriana S. Albuquerque
Adriana S. Albuquerque
ASAna Serra-Caetano
Ana Serra-Caetano
RFRussell B. Foxall
Russell B. Foxall
APAna R. Pires
Ana R. Pires
ASAna E Sousa
Ana E Sousa
Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7

5 March 2014 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SFSusana Mendes Fernandes
Susana Mendes Fernandes
APAna R. Pires
Ana R. Pires
CFCristina Ferreira
Cristina Ferreira
RFRussell B. Foxall
Russell B. Foxall
JRJosé Rino
José Rino
ASAna E Sousa
Ana E Sousa
Background. Interleukin 22 (IL-22) is emerging as a key cytokine for gut epithelial homeostasis and mucosal repair. Gut disruption is a hallmark of human immunodeficiency virus (HIV) infection. Here, we investigated IL-22 production and gut mucosal integrity in HIV type 1 (HIV-1)–infected individuals receiving long-term antiretroviral therapy (ART). Methods. Biopsy specimens from 37 individuals who underwent colonoscopy primarily for cancer screening and from 17 HIV-1–infected and 20 healthy age-matched controls were assessed. Results. We found significant depletion of sigmoid IL-22–producing CD4+ T cells (T-helper type 22 [Th22] cells) even after prolonged ART, contrasting with the apparently normal compartments of regulatory and interleukin 17 (IL-17)–producing CD4+ T cells, as well as total mucosal CD4+ T cells. Despite the preferential Th22 cell depletion, IL-22 production by innate lymphoid cells (ILCs) was similar to that observed in HIV-1–seronegative subjects, and transcription of genes encoding molecules relevant for IL-22 production (ie, AHR, IL23, IL23R, IL1B, IL6, and TGFB1) was preserved. Remarkably, levels of transcripts of IL-22–target genes (ie, REG3G, DEFB4A, S100A9, MUC1, and MUC13) were unaltered, suggesting an adequate production of antimicrobial peptides and mucins. In agreement, enteric epithelial architecture was fully preserved. Conclusions. Despite the reduced Th22 cell subset, innate IL-22–mediated mechanisms, essential for sigmoid mucosa integrity, were fully operational in long-term–treated HIV-1–infected individuals. Our data highlight IL-22 production by ILCs as an important target for therapies aimed at facilitating human mucosal reconstitution.

15 December 2014 in The Journal of Immunology
Verified
Journal Article
Closed access
CMCatarina Mota
Catarina Mota
VNVânia Nunes-Silva
Vânia Nunes-Silva
APAna R Pires
Ana R Pires
PMPaula Matoso
Paula Matoso
RVRui M M Victorino
Rui M M Victorino
ICIris Caramalho
Iris Caramalho
FOXP3-expressing regulatory T cells (Treg) are essential for the prevention of autoimmunity and were shown to be reduced and/or dysfunctional in several autoimmune diseases. Although Treg-based adoptive transfer represents a promising therapy, the large cell number required to achieve clinical efficacy constitutes an important limitation. Therefore, novel strategies to generate bona fide in vitro–induced Treg (iTreg) are critical. In this study, we report that human memory CD4 T cells can be efficiently converted into iTreg, and that Delta-like 1 (DL1)–mediated Notch signaling significantly enhances this process. The iTreg generated in the presence of DL1 featured higher levels of Treg function–associated molecules and were efficient suppressors. Importantly, these iTreg displayed a stable phenotype in long-term cultures, even in the presence of proinflammatory cytokines. Additionally, DL1 potentiated FOXP3 acquisition by memory CD4 cells through the modulation of the TGF-β signaling pathway and of Foxp3 transcription. Our data demonstrate that iTreg can be efficiently induced from memory CD4 cells, a subset enriched in relevant specificities for targeting in autoimmune diseases, and that DL1 enhances this process. DL1 also enhanced the proliferation and Treg function–associated marker expression of ex vivo–stimulated human circulating FOXP3+ cells. Manipulation of the Notch signaling pathway constitutes a promising approach to boost the in vitro generation of iTreg and ex vivo Treg expansion, thus facilitating the establishment of effective Treg-based adoptive therapy in autoimmune diseases.

1 January 2018 in Mucosal Immunology
Verified
Journal Article
Closed access
SFSusana Mendes Fernandes
Susana Mendes Fernandes
APA R Pires
A R Pires
PMP Matoso
P Matoso
CFC Ferreira
C Ferreira
HNHelena Nunes-Cabaço
Helena Nunes-Cabaço
ASAna E Sousa
Ana E Sousa